RYTM
Rhythm Pharmaceuticals, Inc.
Stock
$92.83−0.58 (−0.62%)Close Oct 2, 2026
- Shareholders' equity, 2025
- $139M
- YoY, 2025
- +540.0%
- 5-year CAGR
- −3.5%
Shareholders' equity
Shareholders' equity by fiscal year
| Period | Equity | YoY |
|---|---|---|
| 2025 | $139M | +540.0% |
| 2024 | $22M | −87.2% |
| 2023 | $170M | −35.8% |
| 2022 | $264M | −7.0% |
| 2021 | $284M | +70.6% |
| 2020 | $167M | −40.7% |
| 2019 | $281M | +14.1% |
| 2018 | $246M | +70.1% |
| 2017 | $145M | — |
| 2016 | −$33M | — |
| 2015 | −$8.0M | — |